Reactive oxygen species (ROS) include superoxide and its downstream metabolites. These species are known to play multiple roles in both physiology and pathophysiology. A prominent source of ROS in vivo are the NADPH oxidase (Nox) family of enzymes that in humans consists of 7 isoforms (Nox1-5, Duox1, Duox2) with distinct tissue distribution and mechanisms of regulation. The prototypic family member (Nox2) is the classic "respiratory burst oxidase'that produces high levels of ROS under strict regulation that are critical for host defence. ROS important in cellular signaling are produced at more modest levels, often by other Nox isoforms, and have been described in other cell types. In this regard, the Nox4 NADPH oxidase isoform is of particular interest as it constitutively generates ROS in the form of hydrogen peroxide (H2O2) and is regulated principally at the transcriptional level. Emerging data from our previous funding period indicate that Nox4, in contrast to ?O2- producing NADPH oxidase isoforms, promotes physiological vascular adaptation and tissue repair. In this application, we present data supporting our central hypothesis that endothelial Nox4 is required for the adaptive vascular effects of endurance exercise including enhanced NO? bioactivity and thrombosis resistance. To investigate this hypothesis, we will first determine the in vivo role of Nox4 in the vascular response to endurance exercise. For these studies, Nox4-/- and wild-type mice will undergo endurance exercise followed by assessment of vascular adaptation determined as eNOS/NO? bioactivity, and upregulation of antithrombotic (KLF2, thrombomodulin) and antioxidant (Nrf2, PGC-1?) pathways. To determine the specific impact of endothelial Nox4, we will also test exercise-induced vascular adaptation in constitutive and inducible endothelial- specific Nox4 knockout (ECKONox4) models we have created and characterized. We will then determine the role of antioxidant gene regulation in the Nox4 response to endurance exercise as our preliminary data indicate that Nox4 upregulates both Nrf2- and PGC-1?-dependent pathways in the vasculature. Accordingly we will perform our exercise protocol on global (Nrf2-/-, PGC-1?-/-) and endothelial-specific loss-of-function models (ECKONrf2, ECKOPGC-1?), and assess the pathways outlined above in Aim1. We will then determine if PGC-1? is sufficient to mimic exercise-induced vascular adaptation with an animal model of endothelial-specifc PGC-1? upregulation we have created that features enhanced NO? bioactivity. Finally, we will determine the mechanisms regulating Nox4 and its contribution to the endothelial response to endurance exercise. Using an established carotid-to-jugular shunt system, we will model the extent to which increased flow mimics the changes in eNOS/NO?, antithrombotic activity, and antioxidant activity seen with exercise. We will then test this model n Nox4-/- and ECKONox4 mice and determine the impact on NO? bioactivity and the antithrombotic and antioxidant pathways listed above. We will then use human and murine endothelial cell models of Nox4, AMP kinase, Nrf2, and PGC-1? manipulation to determine the molecular mechanisms whereby Nox4 dictates the endothelial response to endurance exercise with regards to NO? bioactivity, thrombosis resistance, and antioxidant upregulation. The experiments outlined above should provide us with a solid working knowledge of how Nox4 contributes to vascular homeostasis. These data will be a key element of determining how ROS can be adaptive in the vasculature and, importantly, how ROS positively regulate NO? bioactivity and thromboresistance. With this information in hand, we should have the requisite insight to design therapies that modulate vascular ROS and better predict their impact on normal vascular physiology and also the pathophysiology of vascular disease.

Public Health Relevance

Reactive oxygen species (ROS) are a chemical species produced in the body that aid in killing invading micro- organisms. It was once thought these compounds were only used to kill cells and cause damage. However, it is now clear that some normal cells produce ROS that are important in normal functions such as wound repair and remodeling if tissues after injury. One of the major families of enzymes that produce ROS are called NADPH oxidases, and they are abbreviated Nox. There are 7 types of these enzymes and we have studies one particular type in endothelial cells known as Nox4. This type of Nox family member produces an ROS known as hydrogen peroxide. Data submitted in this application demonstrates that Nox4-derived hydrogen peroxide helps blood vessels adapt to exercise. In fact, upregulation of this Nox4 enzyme seems responsible for many of the good things that happen to blood vessels with exercise. Our hypothesis is that upregulation of this ROS source makes blood vessels more relaxed and prevents blood clots from forming too easily. This proposal is to study how Nox4 promotes health blood vessels with exercise. We have made mice that lack this enzyme and will subject them to an exercise protocol. We will then determine if their arteries are getting more or less healthy by testing how much they relax and how much they prevent blood clots. To understand precisely now Nox4 works, we will also test endothelial cells in test tubes to determine the signaling pathways involved in Nox4 action. We hope this research will give us insights into how we can manipulate ROS to improve the function of blood vessels.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL098407-05
Application #
8759579
Study Section
Vascular Cell and Molecular Biology Study Section (VCMB)
Program Officer
Gao, Yunling
Project Start
2009-12-01
Project End
2018-06-30
Budget Start
2014-08-01
Budget End
2015-06-30
Support Year
5
Fiscal Year
2014
Total Cost
$473,779
Indirect Cost
$190,926
Name
University of Massachusetts Medical School Worcester
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
603847393
City
Worcester
State
MA
Country
United States
Zip Code
01655
McManus, David D; Beaulieu, Lea M; Mick, Eric et al. (2013) Relationship among circulating inflammatory proteins, platelet gene expression, and cardiovascular risk. Arterioscler Thromb Vasc Biol 33:2666-73
Keaney Jr, John F (2013) P2Y12 inhibition in patients with NSTEMI--can later be better? N Engl J Med 369:1056-7
Shimasaki, Yukio; Pan, Ning; Messina, Louis M et al. (2013) Uncoupling protein 2 impacts endothelial phenotype via p53-mediated control of mitochondrial dynamics. Circ Res 113:891-901
Ward, Natalie C; Chen, Kai; Li, Chunying et al. (2011) Chronic activation of AMP-activated protein kinase prevents 20-hydroxyeicosatetraenoic acid-induced endothelial dysfunction. Clin Exp Pharmacol Physiol 38:328-33
Keaney Jr, John F (2011) Immune modulation of atherosclerosis. Circulation 124:e559-60
Craige, Siobhan M; Chen, Kai; Pei, Yongmei et al. (2011) NADPH oxidase 4 promotes endothelial angiogenesis through endothelial nitric oxide synthase activation. Circulation 124:731-40
Schuhmacher, Swenja; Foretz, Marc; Knorr, Maike et al. (2011) ýý1AMP-activated protein kinase preserves endothelial function during chronic angiotensin II treatment by limiting Nox2 upregulation. Arterioscler Thromb Vasc Biol 31:560-6
Sugamura, Koichi; Keaney Jr, John F (2011) Reactive oxygen species in cardiovascular disease. Free Radic Biol Med 51:978-92
Diaz, J A; Booth, A J; Lu, G et al. (2009) Critical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection. Am J Transplant 9:1773-83